文献速递肝胆胰外科

腹腔镜根治性顺行模块化胰脾切除术在特定早期左侧胰腺癌中的疗效评估:一项倾向性评分匹配研究

Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sided pancreatic cancer: a propensity score matching study.
PubMed 文献 · Surg Endosc · 2024-05-15

该研究回顾了2020年10月至2022年12月间接受LRAMPS(54例)或LDP(131例)的左侧胰腺癌患者,经1:1倾向性评分匹配后各组54例。LRAMPS组手术时间更长、术中出血更多、淋巴结检出数更多,但淋巴结阳性率、R0切缘率及术后并发症无显著差异;LRAMPS组引流液量更多、恢复半流质饮食时间更长、每日排便次数增加,且6个月静脉化疗完成率更低(51.9% vs 75.9%,P=0.016)。作者结论认为在所选标准内LRAMPS未显示优于LDP的肿瘤学获益。

要点

  • 在肿瘤直径≤4 cm、距腹腔干≥1 cm且未侵犯胰腺后筋膜的左侧胰腺癌中,LRAMPS较LDP未显示肿瘤学获益。
  • LRAMPS组手术时间240.5 vs 219.0 min(P=0.020)、术中出血200 vs 150 mL(P=0.001)、引流液量85.0 vs 40.0 mL(P=0.001)均高于LDP组。
  • LRAMPS组6个月静脉化疗完成率51.9% vs LDP组75.9%(P=0.016),作者认为这影响了LRAMPS潜在局部控制优势。

核心结论

  • 在术前影像学选择标准内,LRAMPS对左侧胰腺癌未提供优于LDP的肿瘤学获益,但增加了手术时间、术中出血和术后排便频率,并影响辅助化疗方案选择及完成率,从而可能削弱LRAMPS实现更好局部控制的潜在优势。

研究设计与样本

  • 回顾性倾向性评分匹配研究,纳入2020年10月至2022年12月连续接受LRAMPS(n=54)或LDP(n=131)的左侧胰腺癌患者,经1:1匹配后LRAMPS组54例、LDP组54例。
  • 术前影像学选择标准为:肿瘤直径≤4 cm;距腹腔干≥1 cm;未侵犯胰腺后筋膜层。

主要发现

  • 匹配后LRAMPS组手术时间240.5 min vs LDP组219.0 min(P=0.020),术中出血量200 mL vs 150 mL(P=0.001)。
  • LRAMPS组淋巴结检出数16枚 vs LDP组13枚(P=0.008),但淋巴结阳性率35.2% vs 33.3%、胰腺切缘R0率94.4% vs 96.3%、腹膜后切缘R0率83.3% vs 87.0%均无统计学显著差异。
  • 两组术后并发症无显著差异,但LRAMPS组引流液量85.0 mL vs LDP组40.0 mL(P=0.001)、恢复半流质饮食时间5天 vs 4天(P<0.001)及每日排便频率增加。
  • 两组肿瘤复发模式和無复发生存期相当,但辅助化疗方案不同,LRAMPS组6个月静脉化疗完成率51.9% vs LDP组75.9%(P=0.016)。

关键数值与推荐

  • LRAMPS组与LDP组淋巴结阳性率分别为35.2%和33.3%,差异无统计学显著意义。
  • LRAMPS组与LDP组胰腺切缘R0率分别为94.4%和96.3%,腹膜后切缘R0率分别为83.3%和87.0%,差异均无统计学显著意义。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic radical pancreatectomy is safe and beneficial for recectable pancreatic cancer, but the extent of resection for early-stage tumors remains controversial. METHODS: Consecutive patients with left-sided pancreatic cancer who underwent either laparoscopic radical antegrade modular pancreatosplenectomy (LRAMPS, n = 54) or laparoscopic distal pancreatosplecnectomy (LDP, n = 131) between October 2020 and December 2022 were reviewed. The preoperative radiological selection criteria were as follows: (1) tumor diameter ≤ 4 cm; (2) located ≥ 1 cm from the celiac trunk; (3) didn't invade the fascial layer behind the pancreas. RESULTS: After 1:1 propensity score matching (LRAMPS, n = 54; LDP, n = 54), baseline data were well-balanced with no differences. LRAMPS resulted in longer operation time (240.5 vs. 219.0 min, P = 0.020) and higher intraoperative bleeding volume (200 vs. 150 mL, P = 0.001) compared to LDP. Although LRAMPS harvested more lymph nodes (16 vs. 13, P = 0.008), there were no statistically significant differences in lymph node positivity rate (35.2% vs. 33.3%), R0 pancreatic transection margin (94.4% vs. 96.3%), and retroperitoneal margin (83.3% vs. 87.0%) rate. Postoperative complications did not significantly differ between the two groups. However, LRAMPS was associated with increased drainage volume (85.0 vs. 40.0 mL, P = 0.001), longer time to recover semi-liquid diet compared to LDP (5 vs. 4 days, P < 0.001) and increased daily bowel movement frequency. Tumor recurrence pattern and recurrence-free survival were comparable between the two groups, but the adjuvant chemotherapy regimens varied, and the completion rate of the 6-month intravenous chemotherapy was lower in the LRAMPS group compared to the LDP group (51.9% vs. 75.9%, P = 0.016). CONCLUSIONS: LRAMPS did not provide oncological benefits over LDP for left-sided pancreatic cancer within the selection criteria, but it increased operation time, intraoperative bleeding, and postoperative bowel movement frequency. These factors impacted the regimen selection and completion of adjuvant chemotherapy, consequently compromising the potential benefits of LRAMPS in achieving better local control.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Li Z, Xu W, Wang T, et al. Evaluating the efficacy of laparoscopic radical antegrade modular pancreatosplenectomy in selected early-stage left-sided pancreatic cancer: a propensity score matching study. Surg Endosc. 2024. PMID: 38750173. doi:10.1007/s00464-024-10868-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。